Experiment on the factors for enhancing the susceptibility of cancer cells to chemotherapeutic drug by ultrasound microbubbles

Journal of Drug Targeting

Volumn 18, Issue 6, 2010, Pages 430-437

  Zhao, Ying Zheng ^a   Gao, Hui Sheng ^a   Zhou, Zhi Cai ^a   Tang, Qin Qin ^a   Lu, Cui Tao ^a   Jin, Zhuo ^a   Tian, Ji Lai ^a   Xu, Yan Yan ^a   Tian, Xin Qiao ^a   Wang, Lee ^a   Kong, Fan Lei ^a   Li, Xiao Kun ^a   Huang, Pin Tong ^a   He, Hui Liao ^a   Wu, Yan ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Cancer; Chemotherapy; Microbubbles; Nanobubble; Ultrasound

Indexed keywords

TOPOTECAN; ANTINEOPLASTIC AGENT; PHOSPHOLIPID;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MICROBUBBLE; PARTICLE SIZE; PRIORITY JOURNAL; ULTRASOUND; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; MICROBUBBLES; PHOSPHOLIPIDS; SONICATION; TOPOTECAN; ULTRASONICS;

EID: 77953254828     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903434043     Document Type: Article

References (22)

1. Eisenbrey JR, Huang P, Hsu J, Wheatley MA. (2009). Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents. Ultrasonics, 49: 628-633.
2. Gao Z, Kennedy AM, Christensen DA, Rapoport NY. (2008). Drugloaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics, 48: 260-270.
3. Gao ZG, Fain HD, Rapoport N. (2005). Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release, 102: 203-222.
4. Heller LC, Heller R. (2006). In vivo electroporation for gene therapy. Hum Gene Ther, 17: 890-897.
5. Jain RK. (1996). Delivery of molecular medicine to solid tumors. Science, 271: 1079-1080.
6. Klibanov AL. (2006). Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol, 41: 354-362.
7. Kobayashi Y, Sakai D, Iwashina T, Iwabuchi S, Mochida J. (2009). Low-intensity pulsed ultrasound stimulates cell proliferation, proteoglycan synthesis and expression of growth factor-related genes in human nucleus pulposus cell line. Eur Cell Mater, 17: 15-22.
8. Li T, Tachibana K, Kuroki M, Kuroki M. (2003). Gene transfer with echoenhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice-initial results. Radiology, 229: 423-428.
9. Liu Y, Miyoshi H, Nakamura M. (2006). Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release, 114: 89-99.
10. Marin A, Sun H, Husseini GA, Pitt WG, Christensen DA, Rapoport NY. (2002). Drug delivery in pluronic micelles: effect of highfrequency ultrasound on drug release from micelles and intracellular uptake. J Control Release, 84: 39-47. (Pubitemid 35223412)
11. Porter TR, Xie F, Knapp D, Iversen P, Marky LA, Tsutsui JM, Maiti S, Lof J, Radio SJ, Kipshidze N. (2006). Targeted vascular delivery of antisense molecules using intravenous microbubbles. Cardiovasc Revasc Med, 7: 25-33.
12. Rapoport NY, Kennedy AM, Shea JE, Scaife CL, Nam KH. (2009). Controlled and targeted tumor chemotherapy by ultrasoundactivated nanoemulsions/ microbubbles. J Control Release, 138: 268-276.
13. Ross JP, Cai X, Chiu JF, Yang J, Wu J. (2002). Optical and atomic force microscopic studies on sonoporation. J Acoust Soc Am, 111: 1161-1164.
14. Schutt EG, Klein DH, Mattrey RM, Riess JG. (2003). Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed Engl, 42: 3218-3235.
15. Suzuki M, Koshiyama K, Shinohara F, Mori S, Ono M, Tomita Y, Yano T, Fujikawa S, Vassaux G, Kodama T. (2005). Nanobubbles enhanced drug susceptibility of cancer cells using ultrasound. International Congress Series. 2005; 1284: 338-339.
16. Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Sawamura K, Tanaka K, Namai E, Oda Y, Matsumura Y, Maruyama K. (2008). Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles. J Control Release, 125: 137-144.
17. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. (2004). Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev, 56: 1291-1314.
18. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, Brandenburger GH, Wagner WR. (1998). Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation, 98: 1-5.
19. Zhao YZ, Lu CT, Fu HX, Li XK, Zhou ZC, Zhao GT, Tian JL, Gao HS, Jiang YN, Hu SP, Yang W. (2009). Phospholipid-based ultrasonic microbubbles for loading protein and ultrasound-triggered release. Drug Dev Ind Pharm, 35: 1121-1127.
20. Zhao YZ, Lu CT. (2008). Hypothesis about the physical mechanism of gene transfer mediated by ultrasound contrast agent: chain cavitation effect. Biosci Hypoth, 1: 189-192.
21. Zhao YZ, Luo YK, Liang HD, Mei XG, Tang J, Lu CT, Zhang Y, Lin Q. (2006). Comparing transfection efficiency and safety for antisense oligodeoxyribonucleotide between phospholipids-based microbubbles and liposomes. J Drug Target, 14: 687-693.
22. Zhao YZ, Luo YK, Lu CT, Xu JF, Tang J, Zhang M, Zhang Y, Liang HD. (2008). Phospholipids-based microbubbles sonoporation pore size and reseal of cell membrane cultured in vitro. J Drug Target, 16: 18-25.